Atlas Trials

Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)

Clinical trial NCT00170209 · COMPLETED

Trial details

NCT number
NCT00170209
Sponsor
McGill University
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Latent Tuberculosis Infection
Start date
2011-08-01
Primary completion
2014-11-01
Enrollment
844

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.